1. Who Benefits from Aggressive Rapid Response System Treatments Near the End of Life? A Retrospective Cohort Study 
Magnolia Cardona, PhD, MPH, Robin M. Turner, PhD, MSc, Amanda Chapman, BN, GradDip (Acute Care), Hatem Alkhouri, PhD, MSc, Ebony T. Lewis, MIPH, BN, Stephen Jan, PhD, ME, Margaret Nicholson, MN, DipAppSc, Michael Parr, MBBS, FCICM, Margaret Williamson, MPH, BPharm, Ken Hillman, MD, FCICM 
Joint Commission Journal on Quality and Patient Safety 
Volume 44, Issue 9, Pages (September 2018)
DOI: /j.jcjq
Copyright © 2018 The Joint Commission Terms and Conditions

2. Figure 1
The flow diagram shows the study sampling frame and subsequent patient selection according to availability of 3-month data before and after the rapid response system (RRS) call. Distribution of eligible patients by age group and final outcome of death are also presented.
Joint Commission Journal on Quality and Patient Safety  , DOI: ( /j.jcjq )
Copyright © 2018 The Joint Commission Terms and Conditions

3. Figure 2
The graph illustrates the differences in survival time from the moment of the rapid response system (RRS) call to the end of follow-up. Differentials for those who had limitations of treatment (known to be at high risk of death—lower curve) and those not at high risk (no limitations of treatment—upper curve) indicate that patients with NFR (not-for-resuscitation) or not-for-RRS orders died earlier.
Joint Commission Journal on Quality and Patient Safety  , DOI: ( /j.jcjq )
Copyright © 2018 The Joint Commission Terms and Conditions